Disseminated intravascular coagulation: cause, molecular mechanism, diagnosis, and therapy

被引:0
作者
Gong, Fangchen [1 ]
Zheng, Xiangtao [1 ]
Zhao, Shanzhi [1 ]
Liu, Huan [1 ]
Chen, Erzhen [1 ,2 ]
Xie, Rongli [3 ]
Li, Ranran [4 ]
Chen, Ying [1 ,5 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Emergency, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Shanghai Inst Aviat Med, Med Sch, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg,Lu Wan Branch, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Crit Care Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Emergency & Crit Care Med,Wuxi Branch, Wuxi, Peoples R China
来源
MEDCOMM | 2025年 / 6卷 / 02期
基金
中国国家自然科学基金;
关键词
coagulation; disseminated intravascular coagulation; fibrinolysis; sepsis; trauma; ACTIVATED PROTEIN-C; FACTOR PATHWAY INHIBITOR; HUMAN SOLUBLE THROMBOMODULIN; CRITICALLY-ILL PATIENTS; CELL-BASED MODEL; TISSUE FACTOR; SEVERE SEPSIS; INTERNATIONAL SOCIETY; ANTICOAGULANT-THERAPY; THROMBIN GENERATION;
D O I
10.1002/mco2.70058
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Disseminated intravascular coagulation (DIC) is a complex and serious condition characterized by widespread activation of the coagulation cascade, resulting in both thrombosis and bleeding. This review aims to provide a comprehensive overview of DIC, emphasizing its clinical significance and the need for improved management strategies. We explore the primary causes of DIC, including sepsis, trauma, malignancies, and obstetric complications, which trigger an overactive coagulation response. At the molecular level, DIC is marked by excessive thrombin generation, leading to platelet and fibrinogen activation while simultaneously depleting clotting factors, creating a paradoxical bleeding tendency. Diagnosing DIC is challenging and relies on a combination of existing diagnostic criteria and laboratory tests. Treatment strategies focus on addressing the underlying causes and may involve supportive care, anticoagulation therapy, and other supportive measures. Recent advances in understanding the pathophysiology of DIC are paving the way for more targeted therapeutic approaches. This review highlights the critical need for ongoing research to enhance diagnostic accuracy and treatment efficacy, ultimately improving patient outcomes in those affected by DIC.
引用
收藏
页数:24
相关论文
共 187 条
[1]   Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study [J].
Abraham, E ;
Reinhart, K ;
Svoboda, P ;
Seibert, A ;
Olthoff, D ;
Dal Nogare, A ;
Postier, R ;
Hempelmann, G ;
Butler, T ;
Martin, E ;
Zwingelstein, C ;
Percell, S ;
Shu, V ;
Leighton, A ;
Creasey, AA .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2081-2089
[2]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[3]   Disseminated intravascular coagulation: epidemiology, biomarkers, and management [J].
Adelborg, Kasper ;
Larsen, Julie B. ;
Hvas, Anne-Mette .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) :803-818
[4]   Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation [J].
Ahnstrom, Josefin ;
Petri, Anastasis ;
Crawley, James T. B. .
CURRENT OPINION IN HEMATOLOGY, 2024, 31 (06) :315-320
[5]   SARS-CoV-2 detection with aptamer-functionalized gold nanoparticles [J].
Aithal, Srivatsa ;
Mishriki, Sarah ;
Gupta, Rohit ;
Sahu, Rakesh P. ;
Botos, George ;
Tanvir, Shazia ;
Hanson, Russell W. ;
Puri, Ishwar K. .
TALANTA, 2022, 236
[6]  
Akol H, 2002, Eur J Intern Med, V13, P389, DOI 10.1016/S0953-6205(02)00095-X
[7]   The role of thrombin in haemostasis [J].
Al-Amer, Osama M. .
BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (03) :145-148
[8]   Antithrombin III for critically ill patients [J].
Allingstrup, Mikkel ;
Wetterslev, Jorn ;
Ravn, Frederikke B. ;
Moller, Ann Merete ;
Afshari, Arash .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02)
[9]   Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis [J].
Allingstrup, Mikkel ;
Wetterslev, Jorn ;
Ravn, Frederikke B. ;
Moller, Ann Merete ;
Afshari, Arash .
INTENSIVE CARE MEDICINE, 2016, 42 (04) :505-520
[10]   Recombinant Human Activated Protein C for Adults with Septic Shock A Randomized Controlled Trial [J].
Annane, Djillali ;
Timsit, Jean-Francois ;
Megarbane, Bruno ;
Martin, Claude ;
Misset, Benoit ;
Mourvillier, Bruno ;
Siami, Shidasp ;
Chagnon, Jean-Luc ;
Constantin, Jean-Michel ;
Petitpas, Franck ;
Souweine, Bertrand ;
Amathieu, Roland ;
Forceville, Xavier ;
Charpentier, Claire ;
Tesniere, Antoine ;
Chastre, Jean ;
Bohe, Julien ;
Colin, Gwenhael ;
Cariou, Alain ;
Renault, Alain ;
Brun-Buisson, Christian ;
Bellissant, Eric .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (10) :1091-1097